Literature DB >> 28728821

The Kinetics and the Permeation Properties of Piezo Channels.

R Gnanasambandam1, P A Gottlieb1, F Sachs1.   

Abstract

Piezo channels are eukaryotic, cation-selective mechanosensitive channels (MSCs), which show rapid activation and voltage-dependent inactivation. The kinetics of these channels are largely consistent across multiple cell types and different stimulation paradigms with some minor variability. No accessory subunits that associate with Piezo channels have been reported. They are homotrimers and each ∼300kD monomer has an N-terminal propeller blade-like mechanosensing module, which can confer mechanosensing capabilities on ASIC-1 (the trimeric non-MSC, acid-sensing ion channel-1) and a C-terminal pore module, which influences conductance, selectivity, and channel inactivation. Repeated stimulation can cause domain fracture and diffusion of these channels leading to synchronous loss of inactivation. The reconstituted channels spontaneously open only in asymmetric bilayers but lack inactivation. Mutations that cause hereditary xerocytosis alter PIEZO1 kinetics. The kinetics of the wild-type PIEZO1 and alterations thereof in mutants (M2225R, R2456K, and DhPIEZO1) are summarized in the form of a quantitative model and hosted online. The pore is permeable to alkali ions although Li+ permeates poorly. Divalent cations, notably Ca2+, traverse the channel and inhibit the flux of monovalents. The large monovalent organic cations such as tetramethyl ammonium and tetraethyl ammonium can traverse the channel, but slowly, suggesting a pore diameter of ∼8Å, and the estimated in-plane area change upon opening is around 6-20nm2. Ruthenium red can enter the channel only from the extracellular side and seems to bind in a pocket close to residue 2496.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cryo-EM; Domains; Gating; Kinetics; Modeling; Permeation; Piezo1; Piezo2; Selectivity; Thermodynamics; Transition rates; Yoda1

Mesh:

Substances:

Year:  2017        PMID: 28728821     DOI: 10.1016/bs.ctm.2016.11.004

Source DB:  PubMed          Journal:  Curr Top Membr        ISSN: 1063-5823            Impact factor:   3.049


  7 in total

1.  Mechanosensitive Ion Channels, Axonal Growth, and Regeneration.

Authors:  Leann Miles; Jackson Powell; Casey Kozak; Yuanquan Song
Journal:  Neuroscientist       Date:  2022-04-13       Impact factor: 7.235

Review 2.  Pharmacological inhibition of the mitochondrial Ca2+ uniporter: Relevance for pathophysiology and human therapy.

Authors:  Katalin Márta; Prottoy Hasan; Macarena Rodríguez-Prados; Melanie Paillard; György Hajnóczky
Journal:  J Mol Cell Cardiol       Date:  2020-10-06       Impact factor: 5.000

3.  Estimating kinetic mechanisms with prior knowledge I: Linear parameter constraints.

Authors:  Autoosa Salari; Marco A Navarro; Mirela Milescu; Lorin S Milescu
Journal:  J Gen Physiol       Date:  2018-01-10       Impact factor: 4.086

4.  Functional analyses of heteromeric human PIEZO1 Channels.

Authors:  Radhakrishnan Gnanasambandam; Chilman Bae; Lynn Ziegler; Frederick Sachs; Philip A Gottlieb
Journal:  PLoS One       Date:  2018-11-21       Impact factor: 3.240

5.  Inflammatory signaling sensitizes Piezo1 mechanotransduction in articular chondrocytes as a pathogenic feed-forward mechanism in osteoarthritis.

Authors:  Whasil Lee; Robert J Nims; Alireza Savadipour; Qiaojuan Zhang; Holly A Leddy; Fang Liu; Amy L McNulty; Yong Chen; Farshid Guilak; Wolfgang B Liedtke
Journal:  Proc Natl Acad Sci U S A       Date:  2021-03-30       Impact factor: 11.205

Review 6.  Roles of mechanosensitive channel Piezo1/2 proteins in skeleton and other tissues.

Authors:  Lei Qin; Tailin He; Sheng Chen; Dazhi Yang; Weihong Yi; Huiling Cao; Guozhi Xiao
Journal:  Bone Res       Date:  2021-10-20       Impact factor: 13.567

Review 7.  Adenosine Triphosphate Release and P2 Receptor Signaling in Piezo1 Channel-Dependent Mechanoregulation.

Authors:  Linyu Wei; Fatema Mousawi; Dongliang Li; Sébastien Roger; Jing Li; Xuebin Yang; Lin-Hua Jiang
Journal:  Front Pharmacol       Date:  2019-11-06       Impact factor: 5.810

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.